Cancer

Items 1-10 of 13

Page
per page
Set Descending Direction
  1. FGL1 (human) ELISA Kit
    AG-45B-0022
    AG-45B-0022-KI0196 wellsINQ
    FGL1 (human) ELISA Kit
  2. FNDC4 (human) ELISA Kit
    AG-45B-0028
    AG-45B-0028-KI0196 wellsINQ
    FNDC4 (human) ELISA Kit
  3. ICOSL (B7-H2/CD275) (human) ELISA Kit
    AG-45B-0017
    AG-45B-0017-KI0196 wellsINQ
    ICOSL (B7-H2/CD275) (human) ELISA Kit
  4. IL-1β (human) ELISA Kit
    AG-45B-0021
    AG-45B-0021-KI0196 wellsINQ
    IL-1β (human) ELISA Kit
  5. IL-10 (human) ELISA Kit
    AG-45B-0029
    AG-45B-0029-KI0196 wellsINQ
    IL-10 (human) ELISA Kit
  6. IL-37 (human) ELISA Kit
    AG-45A-0041Y
    AG-45A-0041YEK-KI0196 wells
    CHF 640.00
    AG-45A-0041YTP-KI012 x 96 wells
    CHF 1'050.00
    Standardcurve
  7. LAIR2 (human) Matched Antibody Pair
    REV-31-1371-MK
    REV-31-1371-MK-KI011 SetINQ
    LAIR2 (human) Matched Antibody Pair
  8. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wellsINQ
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  9. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wellsINQ
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us

Items 1-10 of 13

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.